These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 34720049)

  • 41. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer.
    Hong Y; Li Z; Su Y; Pu H; Zhang X
    Crit Rev Eukaryot Gene Expr; 2024; 34(1):55-68. PubMed ID: 37824392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma.
    Fan F; Chen K; Lu X; Li A; Liu C; Wu B
    Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway.
    Huang T; Chen Y; Zeng Y; Xu C; Huang J; Hu W; Chen X; Fu H
    BMC Cancer; 2021 Jul; 21(1):844. PubMed ID: 34294084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer.
    Qiao X; Zhao F
    Bioengineered; 2022 Apr; 13(4):9264-9273. PubMed ID: 35411833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
    Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
    Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
    [No Abstract]   [Full Text] [Related]  

  • 52. lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis.
    Tang D; Geng L; Ma J
    Bioengineered; 2021 Dec; 12(1):4100-4110. PubMed ID: 34288800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
    Tian JB; Cao L; Dong GL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
    Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
    World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
    Fang C; Xu L; He W; Dai J; Sun F
    Cell Cycle; 2019 Dec; 18(23):3288-3299. PubMed ID: 31615303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
    Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
    Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.